Sen. Josh Hawley and Rep. Diana Harshbarger introduced legislation to withdraw FDA approval of mifepristone nationwide, making distribution a federal violation and allowing patients to sue manufacturers.
Twenty-one state attorneys general and 60 members of Congress filed amicus briefs supporting Louisiana's lawsuit challenging the FDA's 2023 policy that removed in-person dispensing requirements for mifepristone, enabling mail-order distribution of abortion drugs.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07044622 |
Transcutaneous Electrical Nerve Stimulation (TENS) for Intrauterine Device (IUD) Insertion Pain |
WITHDRAWN | NA |
| NCT06447233 |
Patient Perspectives Medicaid Title XIX Sterilization Consent Form |
COMPLETED | |
| NCT05505435 |
Continuation of Subcutaneous and Intramuscular Depot Medroxyprogesterone Acetate in Post-abortion Patients |
COMPLETED | PHASE4 |
| NCT05317468 |
Assessing Satisfaction With Contraceptive Counseling Using Telephone Versus Video Telehealth Visits |
COMPLETED | NA |
| NCT05285605 |
Advance Provision of Postpartum Emergency Contraception and Its Effects on Reproductive Autonomy |
COMPLETED | |
| NCT05191238 |
Intrauterine Device (IUD) Self Removal |
TERMINATED | NA |
| NCT05119439 |
Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks |
TERMINATED | PHASE4 |
| NCT04871425 |
Ketamine Versus Fentanyl for Surgical Abortions |
COMPLETED | PHASE4 |
| NCT04651166 |
Effect of Prophylactic Tranexamic Acid on Bleeding Outcomes for Dilation and Evacuation |
COMPLETED | PHASE2 |
| NCT04627805 |
Evaluating MyPath to Enhance Reproductive Autonomy and Liberate Decision-making |
TERMINATED | NA |
